Dr. Harbour is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-2020Fax+1 214-645-2011
Summary
- Dr. Harbour is an ocular oncologist, cancer researcher, educator and innovator in the development of precision medicine for patients with eye cancers like uveal melanoma and retinoblastoma. Dr. Harbour is now Professor and Chair of the Department of Ophthalmology at UT Southwestern Medical Center. Through his distinctive fusion of clinical practice and basic research, Dr. Harbour has contributed numerous scientific discoveries and clinical innovations. He invented the first and only prospectively validated molecular prognostic test for uveal melanoma and discovered two of the most important driver mutations in this cancer (BAP1 and SF3B1). His work led to the discovery of the BAP1 familial cancer syndrome. He has made seminal contributions to the understanding of the retinoblastoma gene and protein. He has contributed many innovations to biopsy and surgical techniques for intraocular tumors. He has a large international referral practice for patients with intraocular tumors and diagnostic dilemmas of macular and retinal diseases. His research uses genetics, genomics, cell biology, animal models, computational biology, and bioinformatics to improve the care of patients with eye cancer. Dr. Harbour has been the principal investigator on major research grants from the National Institutes of Health, and many private foundations. He has authored more than 200 peer-reviewed articles, many in high profile journals such as Science, Cell, and the Nature journals. He has founded several collaborative groups, such as the Collaborative Ocular Oncology Group that is conducting the most rapidly accruing multicenter prospective study ever performed for uveal melanoma. He recently established a new international research consortium to address the role of genetic ancestry in the risk, severity, and outcomes for patients with eye cancers around the world.
Education & Training
- Washington University in St. Louis School of MedicineFellowship, Cancer Research, 1996 - 1999
- University of California (San Francisco)Fellowship, Ocular Oncology/Ophthalmic Pathology, 1995 - 1996
- University of Miami Hospital and ClinicsFellowship, Surgical Retina and Vitreous, 1994 - 1995
- Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1991 - 1994
- Johns Hopkins University School of MedicineClass of 1990
- National Cancer InstituteFellowship, Cancer Research, 1987 - 1988
- Texas A&M UniversityB.S., Biochemistry, Summa Cum Laude, 1981 - 1985
Certifications & Licensure
- CA State Medical License 1995 - Present
- FL State Medical License 2012 - 2025
- TX State Medical License 2021 - 2025
- IL State Medical License 1996 - 2014
- MO State Medical License Active through 2013
- PA State Medical License 1992 - 1994
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
- Paul Henkind Memorial Award and Lecture Macula Society, 2014
- America's Top Doctors Castle Connolly, 2009-2014
- Join now to see all
Clinical Trials
- Validation of a Molecular Prognostic Test for Eye Melanoma Start of enrollment: 2007 May 01
- Vorinostat in Patients With Class 2 High Risk Uveal Melanoma Start of enrollment: 2020 Jan 01
- (Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma Start of enrollment: 2023 Jul 03
Roles: Contact
Publications & Presentations
PubMed
- 2 citations15-Gene Expression Profile andas Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1).J William Harbour, Zelia M Correa, Amy C Schefler, Prithvi Mruthyunjaya, Miguel A Materin
Journal of Clinical Oncology. 2024-10-01 - 1 citationsDo Short Delays in Treatment Affect Uveal Melanoma Prognosis?J William Harbour, Zelia M Correa, Andrew W Stacey
Ophthalmology. 2024-09-01 - 6 citationsPRAME induces genomic instability in uveal melanoma.Stefan Kurtenbach, Margaret I Sanchez, Jeffim Kuznetsoff, Daniel A Rodriguez, Natalia Weich
Oncogene. 2024-02-01
Journal Articles
- The genetics of uveal melanoma: an emerging framework for targeted therapyHarbour JW, Pigment Cell Melanoma Res, 1/1/2012
- Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastomaLandreville S, Ma D, Harbour JW., Curr eyes Res, 1/1/2010
- Commentary: "Bench to bedside in uveal melanoma genetics: the future is now"Harbour JW, Retina Today, 1/1/2010
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Factors Associated with Better Ocular and Systemic Outcomes in Primary Vitreoretinal Lymphoma.Walter SD, Harbour JW, American Society of Retina Specialists Annual Meeting, San Diego, CA, 1/1/2014
- Ciliary body melanocytomas: ultrasonographic characteristics and natural course in 9 patients.Tenzel P, Gonzalez MA, Bermudez A, Harbour JW, Association for Research in Vision and Ophthalmology Annual Meeting, Orlando, FL, 1/1/2014
- Natural history of circumscribed choroidal hemangiomas.Ortiz AG, Gonzalez MA, Harbour JW, Ayres B, Association for Research in Ophthalmology and Vision Science Annual Meeting, Orlando, FL, 1/1/2014
- Join now to see all
Lectures
- Uveal Melanoma - Current Status and Future Directions.New York, NY - 1/1/2014
- Uveal Melanoma - The Present And The Future.Key Largo, FL - 1/1/2014
- Genetic Prognostication in Uveal Melanoma.Tokyo, Japan - 1/1/2014
- Join now to see all
Other
- Interview: "A life and death predictor adds to a cancer's strain."Harbour JW, New York Times
http://www.nytimes.com/2012/07/10/health/genetic-test-changes-game-in-cancer-prognosis.html
1/9/2012 - Interview: "A molecular test of ocular melanoma."Harbour JW, Charles Adler Show
1/3/2012 - Interview: "A need to know the worst news you will ever hear."Harbour JW, CBS News Sunday Morning
http://www.cbsnews.com/8301-3445_162-57556650/a-need-to-know-the-worst-news-you-will-ever-hear/
1/2/2012 - Join now to see all
Grant Support
- The Genetics Of Ocular MelanomaNational Cancer Institute2011–2012
- Molecular Predictive Testing In Ocular MelanomaNational Cancer Institute2006–2012
- Molecular Predictive Testing In Ocular MelanomaNational Center For Research Resources2008–2009
- The Role Of RB In The Retina &Other TissuesNational Eye Institute2000–2009
- Functional Analysis Of The Retinal Regulatory Protein RBNational Eye Institute1998–2002
- Collaborative Ocular Melanoma StudyNational Eye Institute2000–2001
Professional Memberships
- Member
- Member
- Member
- American Association of Ophthalmic Oncologists and PathologistsMember
- International Society of Ocular OncologyMember
- Macula SocietyMember
- Retina SocietyMember
- Pan-American Ophthalmology SocietyMember
- Association for Research in Vision and OphthalmologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: